Table 2.
Barrier ranking | Clinicians (n = 8) |
Commercial (n = 55) |
Researchers (n = 36) |
---|---|---|---|
1 | Cost-effectiveness | Reimbursement | Manufacturing |
2 | Manufacturing | Manufacturing | Efficacy (cumulative data) |
3 | Regulation | Cost-effectiveness | Reimbursement |